Analystreport

Takeda Pharmaceutical Company Limited (NYSE: TAK) had its price target raised by analysts at TD Cowen from $24.00 to $30.00. They now have an "outperform" rating on the stock.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK)